Results 281 to 290 of about 428,204 (309)

SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling

Cancer Cell, 2017
Brian Robinson, Andrea Sboner, Sunita Shankar   +2 more
exaly  

PI3K

2006
openaire   +1 more source

PI3K pathway alterations in cancer: variations on a theme

Oncogene, 2008
Lewis C. Cantley
exaly  

PI3K

2012
openaire   +1 more source

PI3K

2018
openaire   +1 more source

PI3K

2005
openaire   +1 more source

Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer

European Journal of Medicinal Chemistry, 2019
Deena S Lasheen, Khaled A M Abouzid
exaly  

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

Seminars in Cancer Biology, 2019
Ali S Alzahrani
exaly  

Structural Determinants of Isoform Selectivity in PI3K Inhibitors

Biomolecules, 2019
Philip E. Thompson, Sandra B. Gabelli, Michelle S Miller   +2 more
exaly  

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4)

Annals of Oncology, 2017
Miguel Martin, Mario Campone, L Dirix
exaly